Polygenic Scores: How well can we separate genetics from the environment?
A person’s traits – such as their height or risk of disease – result from a complex interplay between the genes they inherit and the environments they experience over their lifetime. To cut through some of this complexity, human geneticists use a tool called a polygenic score, which attempts to predict a person’s traits solely from their genes (Rosenberg et al., 2019).
To build a polygenic score, geneticists first enroll a large number of people in a genome-wide association study (GWAS). For each participant, researchers measure numerous genetic variants across their genome, together with a trait of interest, and use this data to determine the extent to which different variants are associated with the trait. This information makes it possible to take the genome of someone who was not involved in the original GWAS and add up the effects of multiple genetic variants to calculate a polygenic score for that trait (Figure 1A). These scores have been used to predict a person’s risk of developing a disease (Torkamani et al., 2018), to study our evolutionary past (Rosenberg et al., 2019), and to help understand complex social outcomes (Harden and Koellinger, 2020).
However, efforts to use polygenic scores face substantial obstacles. All human populations exhibit genetic structure – variation in how genetically similar pairs of individuals are to one another – due to the complex history of geographic separation, population mixtures and migrations that have occurred throughout our evolutionary history. If this genetic structure correlates with patterns of environmental variation, it will cause many genetic variants to be incorrectly associated with a trait. This phenomenon, which is known as population stratification, will introduce biases into polygenic scores and undermine their purpose (which is to separate out the genetic component of trait variation).
To overcome this barrier, researchers would ideally measure the relevant environmental effects in the GWAS sample and include them as statistical controls in their analyses. However, it is difficult – if not impossible – to quantify all environmental effects on a given trait. Existing theory suggests that researchers can use the patterns of genetic variation they have already measured to model the genetic structure of the GWAS sample, and use this as statistical control instead (Song et al., 2015; Wang and Blei, 2019). In essence, because the problem arises from correlations between the environmental effects and patterns of genetic structure, it can be solved by controlling for either of them. The difficulty lies in how to correctly model this genetic structure. Geneticists favor a method called principal components analysis (PCA) (Price et al., 2006), as its simplicity and computational feasibility make it easy to apply to massive GWAS datasets. But the approach has limitations, and population stratification remains an issue in practice (Mathieson and McVean, 2012; Berg et al., 2019; Sohail et al., 2019).
Now, in eLife, Arslan Zaidi and Iain Mathieson from the University of Pennsylvania report which PCA models are the most effective at reducing bias in polygenic scores (Zaidi and Mathieson, 2020). To do this, they simulated the genetic data of a single population which had divided into spatially structured sub-groups within the recent past. They then simulated environmental effects on the trait and tested different PCA models to see how well each model controlled for them.
The results showed that the usual approach, known as ‘common PCA’, leads to polygenic scores that inappropriately mirror the environmental effects. Common PCA models calculate genetic structure by only measuring variants that appear in more than 5% of individuals in the GWAS sample. These common variants are typically ancient in origin, and therefore do not adequately capture the genetic structure of populations which have been spatially subdivided in the recent past. It is this failure to capture the genetic structure that results in biased polygenic scores.
On the other hand, rare variants, which appear in only a handful of individuals, are typically recent in origin and therefore reflect the history of recent subdivisions. Zaidi and Mathieson show that for this reason, PCA models built using patterns of genetic structure in rare variants (‘rare PCA’) eliminate biases from polygenic scores more effectively than the ‘common PCA’ technique (Figure 1B). However, this approach is not a panacea. When the environmental factors associated with the trait were localized to one geographic place (e.g. pollution localized to a particular city), even the rare PCA approach could not separate genetic effects from environmental biases (Figure 1C).
Zaidi and Mathieson also explore a more complicated set of simulations which are meant to more accurately mimic the patterns seen in real GWAS datasets, and find that the results are essentially identical to the simplified scenario described above. In all of their simulations, Zaidi and Mathieson know the ground truth, allowing them to experiment with different approaches designed to target the kind of bias they have simulated. In the real world, the ground truth is not known, so it is difficult to have complete confidence that stratification biases have been properly dealt with. Although a long-studied issue, these findings further demonstrate how separating genetic effects from environmental effects is still not a ‘solved’ problem in genetic studies (Lawson et al., 2020).
Studies that use polygenic scores have exploded in number over the past decade, riding a wave of well-founded optimism that they can open up new, otherwise inaccessible, avenues of research. But care is needed to ensure that this powerful tool is applied appropriately. Ultimately, the possibility for misleading results is an unavoidable risk, especially in research that is restricted to non-experimental settings. Zaidi and Mathieson provide several good recommendations for overcoming this, and suggest that a combination of the rare and common PCA approaches will minimize the amount by which environmental effects confound GWAS data. Moving forward, their results highlight the need for further statistical methods that more effectively deal with the biases introduced by environmental effects, especially for sharply distributed factors. In addition, more sensitive diagnostics are needed to assess how environmental effects impact polygenic scores.
References
-
Using genetics for social scienceNature Human Behaviour 4:567–576.https://doi.org/10.1038/s41562-020-0862-5
-
Interpreting polygenic scores, polygenic adaptation, and human phenotypic differencesEvolution, Medicine, and Public Health 2019:26–34.https://doi.org/10.1093/emph/eoy036
-
Testing for genetic associations in arbitrarily structured populationsNature Genetics 47:550–554.https://doi.org/10.1038/ng.3244
-
The personal and clinical utility of polygenic risk scoresNature Reviews Genetics 19:581–590.https://doi.org/10.1038/s41576-018-0018-x
-
The blessings of multiple causesJournal of the American Statistical Association 114:1574–1596.https://doi.org/10.1080/01621459.2019.1686987
Article and author information
Author details
Acknowledgements
We thank Arjun Biddanda, Xiaoheng Cheng, Graham Coop, Doc Edge and John Novembre for comments on earlier drafts, and Arslan Zaidi and Iain Mathieson for answering questions about their paper.
Publication history
- Version of Record published: December 23, 2020 (version 1)
Copyright
© 2020, Blanc and Berg
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 4,157
- views
-
- 298
- downloads
-
- 5
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Epidemiology and Global Health
Paxlovid, a SARS-CoV-2 antiviral, not only prevents severe illness but also curtails viral shedding, lowering transmission risks from treated patients. By fitting a mathematical model of within-host Omicron viral dynamics to electronic health records data from 208 hospitalized patients in Hong Kong, we estimate that Paxlovid can inhibit over 90% of viral replication. However, its effectiveness critically depends on the timing of treatment. If treatment is initiated three days after symptoms first appear, we estimate a 17% chance of a post-treatment viral rebound and a 12% (95% CI: 0–16%) reduction in overall infectiousness for non-rebound cases. Earlier treatment significantly elevates the risk of rebound without further reducing infectiousness, whereas starting beyond five days reduces its efficacy in curbing peak viral shedding. Among the 104 patients who received Paxlovid, 62% began treatment within an optimal three-to-five-day day window after symptoms appeared. Our findings indicate that broader global access to Paxlovid, coupled with appropriately timed treatment, can mitigate the severity and transmission of SARS-Cov-2.
-
- Cancer Biology
- Epidemiology and Global Health
Background:
Age is the most important risk factor for cancer, but aging rates are heterogeneous across individuals. We explored a new measure of aging-Phenotypic Age (PhenoAge)-in the risk prediction of site-specific and overall cancer.
Methods:
Using Cox regression models, we examined the association of Phenotypic Age Acceleration (PhenoAgeAccel) with cancer incidence by genetic risk group among 374,463 participants from the UK Biobank. We generated PhenoAge using chronological age and nine biomarkers, PhenoAgeAccel after subtracting the effect of chronological age by regression residual, and an incidence-weighted overall cancer polygenic risk score (CPRS) based on 20 cancer site-specific polygenic risk scores (PRSs).
Results:
Compared with biologically younger participants, those older had a significantly higher risk of overall cancer, with hazard ratios (HRs) of 1.22 (95% confidence interval, 1.18–1.27) in men, and 1.26 (1.22–1.31) in women, respectively. A joint effect of genetic risk and PhenoAgeAccel was observed on overall cancer risk, with HRs of 2.29 (2.10–2.51) for men and 1.94 (1.78–2.11) for women with high genetic risk and older PhenoAge compared with those with low genetic risk and younger PhenoAge. PhenoAgeAccel was negatively associated with the number of healthy lifestyle factors (Beta = –1.01 in men, p<0.001; Beta = –0.98 in women, p<0.001).
Conclusions:
Within and across genetic risk groups, older PhenoAge was consistently related to an increased risk of incident cancer with adjustment for chronological age and the aging process could be retarded by adherence to a healthy lifestyle.
Funding:
This work was supported by the National Natural Science Foundation of China (82230110, 82125033, 82388102 to GJ; 82273714 to MZ); and the Excellent Youth Foundation of Jiangsu Province (BK20220100 to MZ).